Developer docs
API playgroundTry for free, no card

Search company profiles

HyTest

Full company profile

uuid000ay1t

Namestring
HyTest
Legal namestring
HyTest Ltd.
Company typeenum
Private
Founded yearint
1994
Descriptiontext

HyTest Ltd. is a Finnish biotechnology company founded in 1994 and headquartered in Turku, specializing in the development, manufacture, and supply of immunological reagents for the in vitro diagnostics (IVD) industry. The company produces high-purity monoclonal antibodies (purified to 92%+ on protein G/A sepharose), polyclonal antibodies, native and recombinant antigens (typically >90–95% purity), and sera/plasma products — approximately 693 monoclonal antibodies and 114 antigens in its catalog. Products are organized across multiple clinical areas including cardiac markers (where HyTest is recognized as a leading provider of troponin I immunoassay reagents), inflammation, infectious diseases, blood coagulation, neuroscience, metabolic syndrome, bone metabolism, thyroid disease, tumor markers, fertility, kidney disease, and veterinary diagnostics. Manufacturing operations are ISO 9001 certified.

The company's technical authority is anchored by R&D Director Alexey Katrukha, a founding team member since 1994, professor at Lomonosov Moscow State University, and member of two IFCC SD Working Groups for troponin standardization. HyTest sells on a B2B basis through a 24/7 e-commerce store (shop.hytest.fi), email-based ordering, and wholly-owned regional sales subsidiaries in North America (Mahwah, NJ), China (Shanghai since 2011), and Russia (Moscow since 2016). Pricing is quote-based in Euros, with quantity discounts available for bulk and standing orders, and products are intended for research use only and further manufacturing use. Revenue figures are not publicly disclosed, and the company is privately held.

Short descriptiontext

HyTest is a Finnish biotechnology company founded in 1994 that develops and supplies high-purity monoclonal antibodies, polyclonal antibodies, and antigens for IVD manufacturers and research institutions, with recognized leadership in cardiac troponin reagents and global reach via regional subsidiaries.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersTurku, Finland
HQ citystring
Turku
HQ countrystring
Finland
HQ regionstring
Europe
Markets served

Serves global market

Offices4 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
immunological reagents, monoclonal antibodies, in vitro diagnostics, cardiac biomarkers, antigen production
Industry3 codes
1Biomarker Assay & Reagent Development (LDT/IVD assay design, antibodies/standards/controls)
CodeHLAAAMALPrimaryYes
2IVD Reagents, Assay Kits & Consumables (Non-instrument)
CodeHLAHAAAMPrimaryNo
3Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes)
CodeHLAGAIAIPrimaryNo
NAICS code1 code
  • In-Vitro Diagnostic Substance Manufacturing325413
SIC code1 code
  • In Vitro & In Vivo Diagnostic Substances2835
Product category
In Vitro Diagnostics (IVD) Reagents
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Antibody and Antigen Product Sales
TypeOne Time License
Description

Sale of immunological reagents including monoclonal antibodies, polyclonal antibodies, antigens, and sera/plasma to IVD companies and research institutions. Products are sold by milligram with prices varying by product. Bulk and standing order discounts available.

hytest.fi
2Licensing and Custom Products
TypeLicensing Royalties
Description

Custom antibody products and specialized immunological reagents for specific assay development applications. Products are intended for research use only and further manufacturing use.

hytest.fi
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Technology or R&D, Supply Chain, Operations, Infrastructure, Marketing or Sales
Pricing details2 tiers
1Standard product pricing - varies by product
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Prices vary across the product range. Contact [email protected] for quotes with Cat# and quantity. Quotes valid for 3 months.

hytest.fi
2Bulk and standing order discounts
ModelUnit PricingBilling cadenceMulti-year contract
Notes

Quantity discounts available for bulk and standing orders. Contact for additional information.

hytest.fi
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

HyTest develops, manufactures, and supplies high-purity immunological reagents — monoclonal antibodies, polyclonal antibodies, native and recombinant antigens, and sera/plasma — for in vitro diagnostics (IVD) assay development and research applications. The company is a leading provider of troponin I immunoassay reagents and serves IVD manufacturers and research institutions globally under ISO 9001 certified operations.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

HyTest is a Finnish biotechnology company founded in 1994 that develops and supplies immunological reagents for the in vitro diagnostics (IVD) industry. The company operates as a single unified product portfolio centered on high-quality antibodies and antigens, with two primary product lines: monoclonal/polyclonal antibodies and antigens (native and recombinant). Products are organized into clinical/cisease categories including cardiac markers (where HyTest is a leading provider of troponin I reagents), inflammation markers, blood coagulation and anemia, infectious diseases, neuroscience, metabolic syndrome, bone metabolism, thyroid diseases, tumor markers, fertility/pregnancy, kidney diseases, veterinary diagnostics, and hormones. The company sells directly to IVD manufacturers and research institutions through an online store platform, offering approximately 693 monoclonal antibodies and 114 antigens. All products are intended for research use only and are manufactured under ISO 9001 certified operations.

Product and service11 records
1Monoclonal Antibodies
CategoryImmunological Reagents
Description

High-purity monoclonal antibodies (92%+ purity, purified by protein G or protein A sepharose chromatography) sold to IVD manufacturers and research institutions for immunoassay development.

2Polyclonal Antibodies
CategoryImmunological Reagents
Description

Polyclonal antibodies sold to IVD manufacturers and research institutions for immunoassay development and research applications.

3Antigens
CategoryImmunological Reagents
Description

Recombinant and native antigens for immunoassay development including cardiac markers, infectious disease antigens, and tumor markers, with purity typically >90% or >95%. Sold to IVD manufacturers and research institutions.

4Sera and Plasma
CategoryImmunological Reagents
Description

Sera and plasma products sold to IVD manufacturers and research institutions for assay development and quality control in diagnostic testing.

5Cardiac Marker Reagents
CategoryCardiac Diagnostics Reagents
Description

Cardiac biomarker reagents including troponin I, troponin T, BNP, NT-proBNP, ST2, and other cardiac-related proteins. HyTest is a leading provider of troponin I immunoassay reagents. Sold to IVD manufacturers and research institutions.

6Inflammation Marker Reagents
CategoryInflammation Diagnostics Reagents
Description

Inflammation marker reagents including procalcitonin (PCT), IL-6, CRP, SAA, and other markers for assay development. Sold to IVD manufacturers and research institutions.

7Infectious Disease Reagents
CategoryInfectious Disease Diagnostics Reagents
Description

Immunological reagents for infectious disease diagnostics including HIV, HCV, HBV, SARS-CoV-2, norovirus, influenza, and HPV. Sold to IVD manufacturers and research institutions.

8HyTest Online Store (shop.hytest.fi)
CategoryE-commerce Platform
Description

E-commerce platform for ordering HyTest antibodies, antigens, and other reagents directly with 24/7 availability, real-time pricing after registration, and order tracking.

9Anti-human alpha-fetoprotein (Cat. # 4F16 RP13)
CategoryImmunological Reagents
Description

Monoclonal antibody for alpha-fetoprotein detection, used by IVD manufacturers in tumor marker and prenatal diagnostic assay development.

10Recombinant Hepatitis B Surface Antigen (Cat. # 8HS15)
CategoryInfectious Disease Diagnostics Reagents
Description

Recombinant antigen for Hepatitis B surface antibody (anti-HBs) immunoassay development. Sold to IVD manufacturers for hepatitis B diagnostic assays.

11Recombinant HCV Core Antigen (Cat. # 8HC55)
CategoryInfectious Disease Diagnostics Reagents
Description

Recombinant HCV core antigen for Hepatitis C virus immunoassay development. Sold to IVD manufacturers for hepatitis C diagnostic assays.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

ACROBiosystems supplies recombinant proteins, antibodies, and critical reagents for IVD and biopharma applications globally. Its reagent portfolio and OEM sales motion overlap directly with HyTest's monoclonal antibody/antigen offering, particularly for cardiac and infectious disease IVD manufacturers.

TypeBroad incumbent
Description

DiaSorin is a focused IVD company supplying specialty immunoassay reagents and kits across infectious disease, cardiac, and other specialty areas. While primarily a kit manufacturer, its internal reagent development and antibody sourcing overlap with HyTest's OEM-reagent niche, making it both a potential customer and competitor.

TypeDirect peer
Description

Sino Biological is a China-based reagent manufacturer specializing in recombinant proteins, antibodies, and antigens for research and IVD applications. It competes with HyTest directly in recombinant antigens and monoclonal antibodies for diagnostic test manufacturers worldwide.

TypeDirect peer
Description

Bio-Rad is a leading manufacturer of IVD reagents, antibodies, and clinical diagnostic instruments. Its life science research reagents and clinical diagnostics segments directly overlap HyTest's antibody/antigen catalog and OEM-reagent supply motion, particularly for cardiac and infectious disease assays.

TypeBroad incumbent
Description

MilliporeSigma, the life science arm of Merck KGaA, is one of the largest suppliers of antibodies, recombinant proteins, and IVD reagents globally. Its scale and OEM relationships compete with HyTest's specialty offering, though Merck operates across a much broader life science portfolio.

TypeDirect peer
Description

Abcam, now part of Danaher, is a leading global supplier of antibodies and reagents to research and IVD customers. Its catalog breadth and direct scientific customer engagement mirror HyTest's antibody-centric business model and target IVD OEM audience.

TypeDirect peer
Description

Surmodics provides IVD reagents, antigens, and protein stabilization chemistries to diagnostic test manufacturers. Its OEM reagent focus and biomarker coverage position it as a direct competitor to HyTest's IVD raw material supply business.

TypeDirect peer
Description

Bio-Techne, through its R&D Systems brand, supplies high-quality antibodies, proteins, and assay reagents to research and diagnostic OEM customers. The catalog depth and direct-to-research/IVD positioning closely mirror HyTest's monoclonal antibody and antigen portfolio, especially in inflammation and neuroscience biomarkers.

TypeBroad incumbent
Description

Thermo Fisher Scientific, through its Thermo Scientific and Invitrogen brands, offers an extensive portfolio of antibodies, antigens, and IVD raw materials across thousands of SKUs. As a much larger incumbent with broad catalog and global manufacturing, it competes with HyTest in OEM reagent supply but also operates across instruments, services, and clinical diagnostics.

TypeDirect peer
Description

Fapon is a China-headquartered IVD raw materials and reagent manufacturer offering antibodies, antigens, and assay development services. It competes with HyTest head-to-head for IVD manufacturer OEM contracts, especially in infectious disease and cardiac biomarkers across Asia.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles8 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries3 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

HyTest

In Vitro Diagnostics (IVD) Reagentshytest.fi/home

HyTest is a Finnish biotechnology company founded in 1994 that develops and supplies high-purity monoclonal antibodies, polyclonal antibodies, and antigens for IVD manufacturers and research institutions, with recognized leadership in cardiac troponin reagents and global reach via regional subsidiaries.

What HyTest does

HyTest Ltd. is a Finnish biotechnology company founded in 1994 and headquartered in Turku, specializing in the development, manufacture, and supply of immunological reagents for the in vitro diagnostics (IVD) industry. The company produces high-purity monoclonal antibodies (purified to 92%+ on protein G/A sepharose), polyclonal antibodies, native and recombinant antigens (typically >90–95% purity), and sera/plasma products — approximately 693 monoclonal antibodies and 114 antigens in its catalog. Products are organized across multiple clinical areas including cardiac markers (where HyTest is recognized as a leading provider of troponin I immunoassay reagents), inflammation, infectious diseases, blood coagulation, neuroscience, metabolic syndrome, bone metabolism, thyroid disease, tumor markers, fertility, kidney disease, and veterinary diagnostics. Manufacturing operations are ISO 9001 certified.

The company's technical authority is anchored by R&D Director Alexey Katrukha, a founding team member since 1994, professor at Lomonosov Moscow State University, and member of two IFCC SD Working Groups for troponin standardization. HyTest sells on a B2B basis through a 24/7 e-commerce store (shop.hytest.fi), email-based ordering, and wholly-owned regional sales subsidiaries in North America (Mahwah, NJ), China (Shanghai since 2011), and Russia (Moscow since 2016). Pricing is quote-based in Euros, with quantity discounts available for bulk and standing orders, and products are intended for research use only and further manufacturing use. Revenue figures are not publicly disclosed, and the company is privately held.

HyTest firmographics

Firmographics
Name
HyTest
Legal name
HyTest Ltd.
Website
https://www.hytest.fi/home
Company type
Private
Founded year
1994
Operating status
Operating
Headcount range
11–50 employees
Short description
HyTest is a Finnish biotechnology company founded in 1994 that develops and supplies high-purity monoclonal antibodies, polyclonal antibodies, and antigens for IVD manufacturers and research institutions, with recognized leadership in cardiac troponin reagents and global reach via regional subsidiaries.
Ownership category
akta.pro rank

HyTest industry classification

Industry
Product category
In Vitro Diagnostics (IVD) Reagents
NAICS
In-Vitro Diagnostic Substance Manufacturing (325413)
SIC
In Vitro & In Vivo Diagnostic Substances (2835)
akta.pro primary industry
Biomarker Assay & Reagent Development (LDT/IVD assay design, antibodies/standards/controls) (HLAAAMAL)
akta.pro secondary industries
IVD Reagents, Assay Kits & Consumables (Non-instrument) (HLAHAAAM), Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI)

Keywords

  • Immunological reagents
  • Monoclonal antibodies
  • In vitro diagnostics
  • Cardiac biomarkers
  • Antigen production

Where HyTest is headquartered

Location

Headquarters

HQ city
Turku
HQ country
Finland
HQ region
Europe

Offices4 records

Markets served

HyTest business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Supply Chain, Operations, Infrastructure, Marketing or Sales

Revenue model

  1. Antibody and Antigen Product Sales: Sale of immunological reagents including monoclonal antibodies, polyclonal antibodies, antigens, and sera/plasma to IVD companies and research institutions. Products are sold by milligram with prices varying by product. Bulk and standing order discounts available.
  2. Licensing and Custom Products: Custom antibody products and specialized immunological reagents for specific assay development applications. Products are intended for research use only and further manufacturing use.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goStandard product pricing - varies by product
Unit PricingMulti-year contractBulk and standing order discounts

Go-to-market motion1 record

Distribution channels5 records

Marketing channels7 records

HyTest product offering

Product offering

Core offering

HyTest develops, manufactures, and supplies high-purity immunological reagents — monoclonal antibodies, polyclonal antibodies, native and recombinant antigens, and sera/plasma — for in vitro diagnostics (IVD) assay development and research applications. The company is a leading provider of troponin I immunoassay reagents and serves IVD manufacturers and research institutions globally under ISO 9001 certified operations.

Product overview

HyTest is a Finnish biotechnology company founded in 1994 that develops and supplies immunological reagents for the in vitro diagnostics (IVD) industry. The company operates as a single unified product portfolio centered on high-quality antibodies and antigens, with two primary product lines: monoclonal/polyclonal antibodies and antigens (native and recombinant). Products are organized into clinical/cisease categories including cardiac markers (where HyTest is a leading provider of troponin I reagents), inflammation markers, blood coagulation and anemia, infectious diseases, neuroscience, metabolic syndrome, bone metabolism, thyroid diseases, tumor markers, fertility/pregnancy, kidney diseases, veterinary diagnostics, and hormones. The company sells directly to IVD manufacturers and research institutions through an online store platform, offering approximately 693 monoclonal antibodies and 114 antigens. All products are intended for research use only and are manufactured under ISO 9001 certified operations.

Differentiator

Problem solved

Functional benefit

Products and services

  • Monoclonal Antibodies High-purity monoclonal antibodies (92%+ purity, purified by protein G or protein A sepharose chromatography) sold to IVD manufacturers and research institutions for immunoassay development.
  • Polyclonal Antibodies Polyclonal antibodies sold to IVD manufacturers and research institutions for immunoassay development and research applications.
  • Antigens Recombinant and native antigens for immunoassay development including cardiac markers, infectious disease antigens, and tumor markers, with purity typically >90% or >95%. Sold to IVD manufacturers and research institutions.
  • Sera and Plasma Sera and plasma products sold to IVD manufacturers and research institutions for assay development and quality control in diagnostic testing.
  • Cardiac Marker Reagents Cardiac biomarker reagents including troponin I, troponin T, BNP, NT-proBNP, ST2, and other cardiac-related proteins. HyTest is a leading provider of troponin I immunoassay reagents. Sold to IVD manufacturers and research institutions.
  • Inflammation Marker Reagents Inflammation marker reagents including procalcitonin (PCT), IL-6, CRP, SAA, and other markers for assay development. Sold to IVD manufacturers and research institutions.
  • Infectious Disease Reagents Immunological reagents for infectious disease diagnostics including HIV, HCV, HBV, SARS-CoV-2, norovirus, influenza, and HPV. Sold to IVD manufacturers and research institutions.
  • HyTest Online Store (shop.hytest.fi) E-commerce platform for ordering HyTest antibodies, antigens, and other reagents directly with 24/7 availability, real-time pricing after registration, and order tracking.
  • Anti-human alpha-fetoprotein (Cat. # 4F16 RP13) Monoclonal antibody for alpha-fetoprotein detection, used by IVD manufacturers in tumor marker and prenatal diagnostic assay development.
  • Recombinant Hepatitis B Surface Antigen (Cat. # 8HS15) Recombinant antigen for Hepatitis B surface antibody (anti-HBs) immunoassay development. Sold to IVD manufacturers for hepatitis B diagnostic assays.
  • Recombinant HCV Core Antigen (Cat. # 8HC55) Recombinant HCV core antigen for Hepatitis C virus immunoassay development. Sold to IVD manufacturers for hepatitis C diagnostic assays.

Companies that use HyTest

Customer profile

Segments3 records

Ideal customer profiles3 records

HyTest technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

HyTest partnerships and signals

Strategic signal

Scale indicators2 records

Recent moves8 records

Expansion highlights6 records

HyTest competitors and assessment

Company assessment

Direct peers

  • ACROBiosystems: ACROBiosystems supplies recombinant proteins, antibodies, and critical reagents for IVD and biopharma applications globally. Its reagent portfolio and OEM sales motion overlap directly with HyTest's monoclonal antibody/antigen offering, particularly for cardiac and infectious disease IVD manufacturers.
  • Sino Biological: Sino Biological is a China-based reagent manufacturer specializing in recombinant proteins, antibodies, and antigens for research and IVD applications. It competes with HyTest directly in recombinant antigens and monoclonal antibodies for diagnostic test manufacturers worldwide.
  • Bio-Rad Laboratories: Bio-Rad is a leading manufacturer of IVD reagents, antibodies, and clinical diagnostic instruments. Its life science research reagents and clinical diagnostics segments directly overlap HyTest's antibody/antigen catalog and OEM-reagent supply motion, particularly for cardiac and infectious disease assays.
  • Abcam (Danaher): Abcam, now part of Danaher, is a leading global supplier of antibodies and reagents to research and IVD customers. Its catalog breadth and direct scientific customer engagement mirror HyTest's antibody-centric business model and target IVD OEM audience.
  • Surmodics: Surmodics provides IVD reagents, antigens, and protein stabilization chemistries to diagnostic test manufacturers. Its OEM reagent focus and biomarker coverage position it as a direct competitor to HyTest's IVD raw material supply business.
  • Bio-Techne (R&D Systems): Bio-Techne, through its R&D Systems brand, supplies high-quality antibodies, proteins, and assay reagents to research and diagnostic OEM customers. The catalog depth and direct-to-research/IVD positioning closely mirror HyTest's monoclonal antibody and antigen portfolio, especially in inflammation and neuroscience biomarkers.
  • Fapon Biotech: Fapon is a China-headquartered IVD raw materials and reagent manufacturer offering antibodies, antigens, and assay development services. It competes with HyTest head-to-head for IVD manufacturer OEM contracts, especially in infectious disease and cardiac biomarkers across Asia.

Broad incumbents

  • DiaSorin: DiaSorin is a focused IVD company supplying specialty immunoassay reagents and kits across infectious disease, cardiac, and other specialty areas. While primarily a kit manufacturer, its internal reagent development and antibody sourcing overlap with HyTest's OEM-reagent niche, making it both a potential customer and competitor.
  • Merck KGaA (MilliporeSigma): MilliporeSigma, the life science arm of Merck KGaA, is one of the largest suppliers of antibodies, recombinant proteins, and IVD reagents globally. Its scale and OEM relationships compete with HyTest's specialty offering, though Merck operates across a much broader life science portfolio.
  • Thermo Fisher Scientific: Thermo Fisher Scientific, through its Thermo Scientific and Invitrogen brands, offers an extensive portfolio of antibodies, antigens, and IVD raw materials across thousands of SKUs. As a much larger incumbent with broad catalog and global manufacturing, it competes with HyTest in OEM reagent supply but also operates across instruments, services, and clinical diagnostics.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

HyTest social profiles

Digital presence

HyTest compliance and trust

Trust signal

Compliance1 record

HyTest financial estimates

Financial estimate

Revenue estimate

Valuation estimate

HyTest leadership team

Management profile

Number of profiles

Profiles8 records

HyTest subsidiaries and ownership

Company hierarchy

Subsidiaries3 records

HyTest funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

HyTest M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about HyTest

What does HyTest do?

HyTest develops, manufactures, and supplies high-purity immunological reagents — monoclonal antibodies, polyclonal antibodies, native and recombinant antigens, and sera/plasma — for in vitro diagnostics (IVD) assay development and research applications. The company is a leading provider of troponin I immunoassay reagents and serves IVD manufacturers and research institutions globally under ISO 9001 certified operations.

Is HyTest a public or private company?

HyTest is a private company. It is classified as private equity controlled and is currently operating.

When was HyTest founded?

HyTest was founded in 1994. It employs 11 to 50 people.

Where is HyTest based?

HyTest is headquartered in Turku, Finland, in the Europe region.

How does HyTest make money?

Two revenue lines are on record. Antibody and Antigen Product Sales are the primary driver. The others are licensing and Custom Products.

Who are HyTest's main competitors?

Direct peers on record are ACROBiosystems, Sino Biological, Bio-Rad Laboratories, Abcam (Danaher), Surmodics, Bio-Techne (R&D Systems) and Fapon Biotech. Broad incumbents are DiaSorin, Merck KGaA (MilliporeSigma) and Thermo Fisher Scientific.

Does HyTest have an API?

No public API is recorded for HyTest.

What industry is HyTest in?

HyTest's product category is In Vitro Diagnostics (IVD) Reagents. Its primary akta.pro industry code is HLAAAMAL, Biomarker Assay & Reagent Development (LDT/IVD assay design, antibodies/standards/controls), with a secondary code of HLAHAAAM, IVD Reagents, Assay Kits & Consumables (Non-instrument). Its NAICS code is 325413 and its SIC code is 2835.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
HytestHyTest Veterinary Diagnostics ProductsHyTest is seeking collaboration partners in the veterinary diagnostics segment to develop species-specific immunoreagents and diagnostic tests for companion and production animals. The company highlights its existing portfolio of monoclonal antibodies and purified antigens, noting that market research indicates positive growth driven by consumer willingness to invest in pet well-being. HyTest aims to address the challenge of lacking species-specific reagents by offering raw materials optimized for animal diagnostics rather than human kits.PR NewswireMindray breidt zijn portfolio voor cardiale biomarkers uit met geavanceerde hs-cTnI- en NT-proBNP-testen, voor verbeterde zorg van hart- en vaatziektenMindray has launched high-sensitivity troponin I (hs-cTnI) and NT-proBNP cardiac biomarker tests, expanding its cardiac biomarker portfolio for diagnosing and treating cardiovascular diseases. The tests, developed in collaboration with HyTest and validated by the Wuhan Asian Heart Hospital in China and Hennepin Healthcare Research Institute in the US, demonstrate strong clinical performance with detection rates exceeding 93% and imprecision below 5%. The hs-cTnI test supports rapid 0-2 hour diagnostic algorithms, while the NT-proBNP test minimizes interference from 55 common cardiac medications.PR NewswireMindray élargit son portefeuille de biomarqueurs cardiaques avec des tests hs-cTnI et NT-proBNP de pointe, renforçant les soins des maladies cardiovasculairesMindray (SZSE: 300760), a global medical device company based in Shenzhen, has expanded its cardiac biomarker portfolio with two new diagnostic tests — a high-sensitivity troponin I (hs-cTnI) test and an NT-proBNP test — developed in collaboration with its subsidiary HyTest.PR NewswireMindray расширяет портфель сердечных биомаркеров передовыми анализами hs-cTnI и NT-proBNPКомпания Mindray (SZSE: 300760) объявила о расширении портфеля сердечных биомаркеров за счёт добавления двух новых анализов — высокочувствительного тропонина I (hs-cTnI) и NT-proBNP, предназначенных для ранней диагностики и мониторинга сердечно-сосудистых заболеваний. Анализы были разработаны совместно с дочерней компанией HyTest, чей комплексный материал кардиотропонина в 2004 году был выбран ассоциацией AACC в качестве международного стандарта тропонинов. Оба анализа прошли клиническую валидацию в кардиологической больнице Wuhan Asian Heart Hospital (Китай) и исследовательском институте Hennepin Healthcare Research Institute (США), продемонстрировав высокие показатели: анализ hs-cTnI достиг 93% коэффициента обнаружения при коэффициенте вариации менее 5%, а NT-proBNP — коэффициента вариации не более 5% с минимизацией помех от 55 распространённых кардиологических препаратов.PR NewswireMindray erweitert sein Biomarker-Portfolio für die Kardiologie um hochmoderne hs-cTnI- und NT-proBNP-Tests, die eine verbesserte Versorgung bei Herz-Kreislauf-Erkrankungen ermöglichenMindray (SZSE: 300760) has launched high-sensitivity Troponin I (hs-cTnI) and NT-proBNP cardiac biomarker tests, expanding its cardiovascular disease diagnostic portfolio through a collaboration with its subsidiary HyTest. The tests, validated by Wuhan Asian Heart Hospital in China and Hennepin Healthcare Research Institute in the USA, demonstrate strong clinical performance with hs-cTnI achieving a 93% detection rate and both assays maintaining a CV of under 5%. Mindray's scientific director highlighted that the integration of HyTest's antibodies with Mindray's reagent technology will deliver more reliable solutions for improved patient outcomes in cardiovascular care.PR NewswireMindray amplía su cartera de biomarcadores cardíacos con ensayos hs-cTnI y NT-proBNP de vanguardia para mejorar la atención de enfermedades cardiovascularesMindray announced the expansion of its cardiac biomarker portfolio with two new assays: high-sensitivity troponin I (hs-cTnI) and NT-proBNP for cardiovascular disease diagnosis and management. The assays were developed in collaboration with HyTest, a Mindray subsidiary and global supplier of antibodies and antigens, and were validated by Wuhan Asian Heart Hospital in China and Hennepin Healthcare Research Institute in the United States. The hs-cTnI assay achieves a 93% detection rate and CV below 5%, while the NT-proBNP assay demonstrates high precision with minimal interference from 55 common cardiac medications.PR NewswireMindray Expands Its Cardiac Biomarker Portfolio with Cutting-Edge hs-cTnI and NT-proBNP Assays, Empowering Enhanced Cardiovascular Diseases CareMindray (SZSE: 300760) has launched two new cardiac biomarker assays—a high-sensitivity troponin I (hs-cTnI) and NT-proBNP—expanding its portfolio for cardiovascular disease diagnosis and management. The assays, developed in collaboration with subsidiary HyTest, demonstrated strong clinical performance in validation studies conducted at Wuhan Asian Heart Hospital and Hennepin Healthcare Research Institute, with the hs-cTnI achieving a 93% detection rate and both assays maintaining imprecision below 5%. These additions position Mindray to address the global burden of cardiovascular diseases, which remain the leading cause of death worldwide.PR NewswireMindray Expands Its Cardiac Biomarker Portfolio with Cutting-Edge hs-cTnI and NT-proBNP Assays, Empowering Enhanced Cardiovascular Diseases CareMindray (SZSE: 300760), a global medical devices company, has expanded its cardiac biomarker portfolio with high-sensitivity troponin I (hs-cTnI) and NT-proBNP assays developed in collaboration with its subsidiary HyTest. The assays, validated by Wuhan Asian Heart Hospital in China and Hennepin Healthcare Research Institute in the U.S., demonstrate high clinical performance with detection rates of 93% and imprecision CV below 5%. Mindray's hs-cTnI assay meets the minimum requirements for high-sensitivity troponin testing, while the NT-proBNP assay shows strong anti-interference capacity against 55 common cardiac medications.PrivateequitywireSumma Equity to sell HyTest to Mindray for EUR545mSumma Equity is selling HyTest, a developer of antibodies and antigens, to global medical technology company Mindray for approximately EUR545 million. The transaction, which includes HyTest's IVD test products used on over 300 million patients annually, is subject to regulatory approvals and expected to close in the second half of the year.news.cision.comSumma Equity has agreed to sell HyTest to Mindray for €545 millionSumma Equity has signed a definitive agreement to sell HyTest, a producer of antibodies and antigens, to Mindray for approximately €545 million. This transaction aligns with Summa Equity’s investment philosophy aimed at addressing global health challenges and is anticipated to complete in the second half of the year, pending regulatory approvals.